Amyotrophic lateral sclerosis


ALS/MND Global Day's icon

Every year the International Alliance of ALS/MND Associations celebrates 21 June as the global day of recognition of ALS/MND – a disease that affects people in every country of the globe.


ALS/MND Global Day's icon

Every year the International Alliance of ALS/MND Associations celebrates 21 June as the global day of recognition of ALS/MND – a disease that affects people in every country of the globe.


Annals of Neurology logo

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder in which the loss of upper and lower motor neurons produces progressive weakness and eventually death. In the decades since the approval of riluzole, the only US Food and Drug Administration-approved medication to moderately slow progression of ALS, no new therapeutics have arisen to alter the course of the disease.


International Alliance of ALS/MND Associations' logo

The International Alliance of ALS/MND Associations was founded in 1992 to provide an international community for individual ALS/MND associations from around the world.


ALS/MND Global Day's icon

Every year the International Alliance of ALS/MND Associations celebrates 21 June as the global day of recognition of ALS/MND – a disease that affects people in every country of the globe.


Hack a Day - Amyotrophic lateral sclerosis (ALS) is a debilitating disease that eventually causes the afflicted individual to lose all control of their motor functions, while leaving their mental faculties intact. Those suffering from the illness typically live for only a handful of years before succumbing to the disease.


Subscribe to Amyotrophic lateral sclerosis